Navigation Links
Soligenix Reports Third Quarter 2011 Financial Results
Date:11/14/2011

e recommendation of an independent Data Safety Monitoring Board.  While we continue to analyze the dataset from this trial, we remain committed to evaluating all strategic options to re-establish the value of Soligenix, including through the development of our oral BDP programs for pediatric Crohn's disease, acute radiation syndrome and acute radiation enteritis as well as through our vaccines/biodefense programs with our novel thermostability technology and ricin toxin vaccine. We look forward to making news in some of these areas in the not too distant future."

Soligenix's Third Quarter and Recent News:

  • On October 11, 2011, Soligenix announced the formation of a Medical Advisory Board (MAB) to provide medical/clinical strategic guidance related to the development of SGX203 (oral beclomethasone dipropionate, or oral BDP) for the treatment of pediatric Crohn's disease.
  • On September 15, 2011, Soligenix announced the recommendation of an independent Data Safety Monitoring Board to stop its confirmatory Phase 3 clinical trial for orBec® in the treatment of acute GI GVHD for futility.
  • On July 28, 2011, Soligenix announced the expansion and amendment of its North American licensing partnership with Sigma-Tau for the development and commercialization of orBec® (oral beclomethasone dipropionate or Oral BDP) into the European territory. As part of the amended agreement, Sigma-Tau made a $5 million payment to Soligenix. 

About Soligenix, Inc.

Soligenix is a development stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate), is a potent, locally acting corticosteroid that has been initially developed for the treatment of acute
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
2. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
3. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
4. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
5. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
6. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
7. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
11. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Reportbuyer.com has added a new market ... 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... a special type of X-ray test used to measure ... primarily to detect osteopenia or osteoporosis, diseases in which ... fractures is high. The purpose of bone densitometry is ...
(Date:7/28/2014)... , July 28, 2014  Some 2,500 scientists and ... in Montreal for the largest ... a discipline that draws researchers from fields as far ... as diverse as designing new manufacturing processes to creating ... special time because the United Nations has declared 2014 ...
(Date:7/28/2014)... Pa. , July 28, 2014  Air Products ... uninterrupted supply of medical oxygen is vital to any ... technical innovations that not only improve the efficiency of ... Air Products will highlight these systems—including systems for ... reduce oxygen loss—from August 4-5 at the 51 ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3
... Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to ... website, www.solosendoscopy.com on Friday July 1, 2011. ... existing and new customers and includes comprehensive information for ... showcases streamlined navigation to allow for easy-to-use functionality, allowing ...
... Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), ... system diseases, announced today that it has expanded its ... Phase IIb clinical trial of patients suffering from amyotrophic ... Preparations are underway to evaluate the safety and efficacy ...
Cached Medicine Technology:Solos Endoscopy, Inc. To Launch New Corporate Website 2Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 2Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 3Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 4Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 5Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 6Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 7
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... who are at risk of contracting meningitis because of ... according to updated recommendations from the largest pediatrician group ... for the potentially deadly infection should continue for adolescents ... In its first statement on meningococcal vaccines since ...
(Date:7/28/2014)... -- Endurance runners are far more likely to die ... to a new study. The researchers pointed ... climates are actually 10 times more likely to develop ... sudden death of a young and apparently healthy person ... heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... DC (PRWEB) July 28, 2014 SIMpalm ... app for iOS, App is available on iTunes for ... of its kind, Audio Chef allows you to listen and ... cuisine the easy way: simply get out the ingredients and ... need to measure or prepare ingredients ahead of time, just ...
(Date:7/28/2014)... York, NY (PRWEB) July 28, 2014 ... literacy organization that has donated more than 200,000 books ... in 2001, announces the launch of Brooke’s Cooks, a ... values, while encouraging healthy living among at-risk children and ... Cooks will include a series of nutrition information workshops, ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, ... sleep apnea in children, but a new study confirms that ... they,re already overweight. The researchers said that,s a concern, ... health problems -- including, ironically, sleep apnea. But they,re not ... they said, doctors and parents should be aware that a ...
Breaking Medicine News(10 mins):Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 2Health News:Tonsillectomy for Sleep Apnea May Trigger Weight Gain 3
... large, sound- and light-proof tanks with high-salt waterfloatingis ... This has been shown by Sven-ke Bood, who ... dissertation from Karlstad University in Sweden. , ... sleep was improved, patients felt more optimistic, and ...
... watched such fare more likely to act out at 7, ... Preschool boys exposed to violent television -- even cartoons -- ... warn. , Their findings don,t definitively prove that TV makes ... fare, according to the researchers. But the link does appear ...
... Robarts Research Institute have developed a simplified and more effective ... led by clinical pharmacologist Dr. Ross Feldman, showed that more ... extent - when their family doctors used a simplified treatment ... of drugs available to treat high blood pressure. While the ...
... Alan, Inc. today launched its,new healthcare-focused Sovereign and ... by NuBax Limited at the Healthcare,Design.07 Conference. Charles ... in the nation, recognized not only for its ... Sovereign and Winston,Series are available in the United ...
... and Awareness for HIV/AIDS, WASHINGTON, Nov. 5 ... protecting young people from,HIV/AIDS, gathered leading celebrities, public ... awareness to fight this pandemic around,the world. The ... and presented by AOL, The Sheila C. Johnson ...
... ORLANDO, Fla., Nov. 5 CV Therapeutics, Inc.,(Nasdaq: ... extended-release,tablets) reduced the relative risk of the primary ... ischemia by 21 percent compared,to placebo in 1,935 ... peptide (BNP) in the MERLIN TIMI-36 study (p=0.009). ...
Cached Medicine News:Health News:Floating effective for stress and pain 2Health News:TV Violence May Spur Aggression in Boys 2Health News:TV Violence May Spur Aggression in Boys 3Health News:Changing the way doctors treat high blood pressure 2Health News:Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits 2Health News:Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits 3Health News:Charles Alan Launches Healthcare-focused Furniture Lines with NuBax Seating Technology, Offering Smart Design and Health Benefits 4Health News:Hon. Nancy Pelosi, Bono, and YouthAIDS Global Ambassador Ashley Judd Among Celebrities at YouthAIDS Benefit Gala 2Health News:Hon. Nancy Pelosi, Bono, and YouthAIDS Global Ambassador Ashley Judd Among Celebrities at YouthAIDS Benefit Gala 3Health News:Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP 2Health News:Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP 3
Protective Curtain for Barriers can be used on any of our RayShield® Barriers. Whether they are ordered with the barrier or as a retrofit, RayShield Protective Curtains are easy to install with s...
Front Protection with attached Belt Guard, Built-in Back Support; Buckle Closure...
Pregnancy Apron...
All Day Comfort for the Upper Body...
Medicine Products: